[ad_1] Here are the most important news items that investors need to start their trading day:…
Tag: Eisai Co Ltd
Alzheimer’s drug Leqembi promises to give patients more time, but they face a long road to treatment
[ad_1] Hannah Yoon | The Washington Post | Getty Images Leqembi, an Alzheimer’s drug from Biogen…
Patients on Alzheimer’s drug Leqembi see benefits over three years, Eisai study says
[ad_1] The newly FDA approved Alzheimer’s treatment Leqembi is prepared at Abington Neurological Associates in Abington,…
Older GLP-1 drug from Novo Nordisk may slow Alzheimer’s disease progression by protecting the brain, study says
[ad_1] A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter…
Japan stocks rebound to lead gains in Asia as traders assess U.S. inflation data, await BOJ meeting
[ad_1] Japan’s Mount Fuji seen in the Tokyo’s horizon on January 1, 2011. Kazuhiro Nogi |…
European drug regulator rejects Alzheimer’s treatment Leqembi from Biogen, Eisai
[ad_1] European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating…
Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up
[ad_1] A test tube is seen in front of displayed Biogen logo in this illustration taken…
These health-care companies see opportunity ahead from Alzheimer’s drug approval
[ad_1] As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs,…